Возраст домена | 29 лет |
Дата окончания | Истек срок регистрации |
PR | 6 |
ИКС | 10 |
Страниц в Google | 48 |
Страниц в Яндексе | 20 |
Dmoz | Да |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 1714420 |
Alexa Country | 281961 |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Home - Arch Venture Partners
venture capital funds technology venture capital investment information technology life sciences venture capital investing physical sciences venture capital fund ARCH Arch Venture partners
ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences
UTF-8
25.69 КБ
205
1 608 симв.
1 363 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
linkedin.com | 19 | 9 |
0 | 25 | 10 | |
wikipedia.org | 16 | 9 |
0 | 5 | 6 | |
crunchbase.com | 15 | 6 |
0 | 1584 | 494 | |
fiercebiotech.com | 15 | 6 |
0 | 87045 | 19580 | |
bloomberg.com | 14 | 8 |
0 | 563 | 219 | |
forbes.com | 14 | 8 |
0 | 289 | 109 | |
xconomy.com | 14 | 6 |
0 | 99148 | 21714 | |
twitter.com | 10 | 10 |
0 | 11 | 8 | |
facebook.com | 10 | 9 |
0 | 3 | 3 | |
lifescivc.com | 10 | 5 |
0 | 1053342 | 531162 | |
pwc.com | 5 | 7 |
0 | 9647 | 5856 | |
versantventures.com | 4 | 5 |
0 | 1900960 | 691281 | |
cbinsights.com | 4 | 5 |
140 | 19911 | 6793 | |
atlasventure.com | 4 | 6 |
0 | 1148671 | 298478 | |
baycitycapital.com | 3 | 5 |
0 | 6645459 | Нет данных | |
altapartners.com | 3 | 5 |
0 | 3738730 | 463363 | |
Еще 34 сайта после авторизации |
Данные предоставлены сервисом semrush
Domain Name: ARCHVENTURE.COM
Registry Domain ID: 1299366_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2015-03-17T15:35:34Z
Creation Date: 1995-05-15T04:00:00Z
Registrar Registration Expiration Date: 2020-05-16T04:00:00Z
Registrar: NETWORK SOLUTIONS, LLC.
Registrar IANA ID: 2
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Reseller:
Domain Status: clientTransferProhibited http://www.icann.org/epp#clientTransferProhibited
Registry Registrant ID:
Registrant Name: ARCH Venture Partners
Registrant Organization: ARCH Venture Partners
Registrant Street: 8725 W. Higgins Road, Suite 290
Registrant City: Chicago
Registrant State/Province: IL
Registrant Postal Code: 60631
Registrant Country: US
Registrant Phone: +1.7733806600
Registrant Phone Ext:
Registrant Fax: +1.9999999999
Registrant Fax Ext:
Registrant Email: mdavis@ARCHVENTURE.COM
Registry Admin ID:
Admin Name: Simms, Melanie
Admin Organization: ARCH Venture Corporation
Admin Street: 8725 W. Higgins Road
Admin City: Chicago
Admin State/Province: IL
Admin Postal Code: 60631
Admin Country: US
Admin Phone: +1.7733806600
Admin Phone Ext:
Admin Fax: +1.7733806606
Admin Fax Ext:
Admin Email: msimms@ARCHVENTURE.COM
Registry Tech ID:
Tech Name: Simms, Melanie
Tech Organization: ARCH Venture Corporation
Tech Street: 8725 W. Higgins Road
Tech City: Chicago
Tech State/Province: IL
Tech Postal Code: 60631
Tech Country: US
Tech Phone: +1.7733806600
Tech Phone Ext:
Tech Fax: +1.7733806606
Tech Fax Ext:
Tech Email: msimms@ARCHVENTURE.COM
Name Server: NS2.EXCALTECH.COM
Name Server: NS1.EXCALTECH.COM
>>> Last update of whois database: Fri, 17 Jul 2015 20:40:03 GMT <<<
User-agent: *
Disallow: /wp/wp-admin/
Allow: /wp/wp-admin/admin-ajax.php
Disallow: /about/heroimage_about/
Disallow: /about/heroimage_aboutv2/
Disallow: /active-status/featured/
Disallow: /active-status/innovator/
Disallow: /active-status/innovator/page/3/
Disallow: /active-status/innovator/page/4/
Disallow: /active-status/innovator/page/5/
Disallow: /author/dev_admin/
Disallow: /company/908-devices/
Disallow: /company/accelerator-corp/accelerator-corp-2/
Disallow: /company/adesto-technologies/adesto-technologies-2/
Disallow: /company/agbiome/agbiome-2/
Disallow: /company/agios-pharmaceuticals/agios-pharmaceuticals-2/
Disallow: /company/aira-tech/
Disallow: /company/aira-tech/aira-tech-2/
Disallow: /company/alis/
Disallow: /company/alis/alis-2/
Disallow: /company/anchordx/
Disallow: /company/apex-neuro-holdings/
Disallow: /company/aviron/
Disallow: /company/bellerophon-therapeutics/
Disallow: /company/blackthorn-therapeutics/
Disallow: /company/boreal-genomics/
Disallow: /company/caliper-life-sciences/
Disallow: /company/caliper-life-sciences/20-caliper/
Disallow: /company/ciespace/
Disallow: /company/classmates-online/classmates-online-2/
Disallow: /company/codiak-biosciences/codiak-biosciences-2/
Disallow: /company/cooledge-lighting/
Disallow: /company/cytrellis-biosystems/cytrellis-biosystems-2/
Disallow: /company/dantz-development/
Disallow: /company/faraday-pharmaceuticals/faraday-pharmaceuticals-2/
Disallow: /company/fate-therapeutics/
Disallow: /company/genvec/genvec-2/
Disallow: /company/grail/grail-2/
Disallow: /company/hua-medicine/hua-medicine-2/
Disallow: /company/ikaria/ikaria-2/
Disallow: /company/illumina/
Disallow: /company/immusant-2/
Disallow: /company/innovalight/innovalight-2/
Disallow: /company/juno-therapeutics/3-juno_therapeutics_logo/
Disallow: /company/juno-therapeutics/juno-2/
Disallow: /company/kotura/
Disallow: /company/kotura/kotura-2/
Disallow: /company/kythera-biopharmaceuticals/kythera/
Disallow: /company/lifemine-therapeutics/
Disallow: /company/lyell-immunopharma-2/
Disallow: /company/microoptical-devices/microoptical-devices-2/
Disallow: /company/mindstrong/
Disallow: /company/mindstrong/mindstrong-2/
Disallow: /company/nanosys/
Disallow: /company/nextcode-health/
Disallow: /company/nohla-therapeutics/nohla-therapeutics-2/
Disallow: /company/novo-vivo/
Disallow: /company/omniome/
Disallow: /company/page/21/
Disallow: /company/page/4/
Disallow: /company/page/6/
Disallow: /company/petra-pharma/
Disallow: /company/pixelexx-systems/
Disallow: /company/pulmatrix/
Disallow: /company/receptos-2/receptos-5/
Disallow: /company/rodeo-therapeutics/
Disallow: /company/sapphire-energy/
Disallow: /company/scholar-rock/
Disallow: /company/scholar-rock/12-scholar-rock/
Disallow: /company/sienna-biopharmaceuticals/
Disallow: /company/siluria-technologies/siluria-technologies-2/
Disallow: /company/skyline-vet-pharma/skyline-vet-pharma-2/
Disallow: /company/syros-pharmaceuticals/
Disallow: /company/trubion-pharmaceuticals/trubion-pharmaceuticals-2/
Disallow: /company/twist-bioscience/
Disallow: /company/ultivue/
Disallow: /company/vir-biotechnology/twist/
Disallow: /company/vlst/vlst-2/
Disallow: /company/voxel8/voxel8-2/
Disallow: /company/xtera-communications/
Disallow: /company/xtera-communications/xtera-communications-2/
Disallow: /contact/austin/
Disallow: /contact/contactus_hero/
Disallow: /contact/dublin/
Disallow: /contact/fbo-map/
Disallow: /contact/hero_images_contact/
Disallow: /contact/san-francisco/
Disallow: /contact/seattle/
Disallow: /news/contact-hero-fpo/
Disallow: /news/home-hero-fpo/
Disallow: /news/news-hero-fpo/
Disallow: /news/portfolio-hero-fpo/
Disallow: /news/team-hero-fpo/
Disallow: /portfolio/heroimage_portfolio_cellpurple/
Disallow: /portfolio/heroimage_portfolio-2/
Disallow: /portfolio/heroimage_portfolio/
Disallow: /portfolio/heroimage_portfoliov2/
Disallow: /team/ari-nowacek/arinowacek_thumbnail/
Disallow: /team/carol-suh/carol-suh-1/
Disallow: /team/carol-suh/carol-suh-2/
Disallow: /team/clinton-w-bybee/clintbybee_thumb/
Disallow: /team/clinton-w-bybee/clinton_bybee2/
Disallow: /team/corey-ritter/corey-ritter-1/
Disallow: /team/corey-ritter/corey-ritter-2/
Disallow: /team/corey-ritter/corey-ritter-3/
Disallow: /team/corey-ritter/corey-ritter-4/
Disallow: /team/david-cruikshank/davidcruikshank_thumb/
Disallow: /team/george-golumbeski/george-golumbeski-1/
Disallow: /team/george-golumbeski/george-golumbeski-2/
Disallow: /team/george-golumbeski/george-golumbeski-3/
Disallow: /team/jay-parrish/jayparrish_thumb/
Disallow: /team/jean-louis-malinge/jean-louis-malinge-1/
Disallow: /team/jean-louis-malinge/jean-louis-malinge-2/
Disallow: /team/john-evans/john_evans2/
Disallow: /team/john-evans/johnevans_thumb/
Disallow: /team/jonathan-lim/jl_headshot-2/
Disallow: /team/jonathan-lim/jl_headshot/
Disallow: /team/jonathan-lim/jl_hero/
Disallow: /team/keith-crandell/heroheadshots_keith-crandell/
Disallow: /team/keith-lenden/heroheadshot_keithlenden/
Disallow: /team/keith-lenden/keith-lenden-1/
Disallow: /team/keith-lenden/keith-lenden-2/
Disallow: /team/keith-lenden/keith-lenden-3/
Disallow: /team/keith-lenden/keith-lenden-4/
Disallow: /team/keith-lenden/keithlenden_thumb/
Disallow: /team/keith-leonard/keithleonard_thumb/
Disallow: /team/kristina-burow/heroheadshots_kristina-burow-2/
Disallow: /team/kristina-burow/heroheadshots_kristina-burow/
Disallow: /team/kristina-burow/kristinaburow_thumb-2/
Disallow: /team/kristina-burow/kristinaburow_thumb/
Disallow: /team/mark-mcdonnell/heroheadshots_mark-mcdonnell/
Disallow: /team/mark-mcdonnell/markmcdonnell_thumb/
Disallow: /team/nathaniel-david-ph-d/ned-david-1/
Disallow: /team/nathaniel-david-ph-d/ned-david-2/
Disallow: /team/nathaniel-david-ph-d/ned-david-3/
Disallow: /team/nathaniel-david-ph-d/ned-david/
Disallow: /team/nilay-thakar/nilay-thakar-1/
Disallow: /team/nilay-thakar/nilay-thakar-2/
Disallow: /team/nilay-thakar/nilay-thakar-3/
Disallow: /team/nilay-thakar/nilay-thakar-4/
Disallow: /team/paul-berns/hero-shots-1-1/
Disallow: /team/paul-berns/paul-berns-2/
Disallow: /team/paul-berns/paul-berns/
Disallow: /team/paul-thurk/paulthurk_thumb/
Disallow: /team/richard-heyman-ph-d/rich-heyman/
Disallow: /team/robert-t-nelsen/bobnelsen_thumb-2/
Disallow: /team/robert-t-nelsen/bobnelsen_thumb/
Disallow: /team/robert-t-nelsen/heroheadshots_bob-nelsen/
Disallow: /team/sean-kendall/sean-kendall_-2/
Disallow: /team/sean-kendall/sean-kendall_/
Disallow: /team/sean-kendall/seankendall_thumb/
Disallow: /team/steve-gillis/steve-gillis-2/
Disallow: /team/steve-gillis/stevegillis_thumb/
Disallow: /team/steve-gillis/stevegillis/
Disallow: /team/steve-lazarus/stevelazarus_thumb/
Disallow: /team/thomas-brennan/tombrennan_thumb/
Disallow: /team/thomas-daniel/heroheadshots_tomdaniel/
Disallow: /team/thomas-daniel/thomas-daniel_bio/
Disallow: /team/thomas-daniel/thomas-daniel_final-2/
Disallow: /team/thomas-daniel/thomas-daniel_final/
Disallow: /team/thomas-daniel/thomas-daniel-1/
Disallow: /team/thomas-daniel/thomas-daniel-2/
Disallow: /team/thomas-daniel/thomas-daniel-3/
Disallow: /team/thomas-daniel/thomas-daniel-4/
Disallow: /team/thomas-daniel/tomdaniel_thumb/
США - 209.68.19.102
pair Networks
pair Networks
HTTP/1.1 200 OK
Server: nginx
Date: Sat, 04 Jan 2020 11:34:14 GMT
Content-Type: text/html; charset=UTF-8
Transfer-Encoding: chunked
Connection: keep-alive
Vary: Accept-Encoding
Link: ; rel="https://api.w.org/"
Link: ; rel=shortlink
X-Kinsta-Cache: HIT
X-Content-Type-Options: nosniff
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"